Results 1 to 10 of about 2,695 (76)

Modified hemolytic plaque technique for the detection of bluetongue virus antibody-forming cells [PDF]

Infection and Immunity, 1976
A hemolytic plaque assay was developed for the detection of antibody-forming cells to bluetongue virus (BTV). Sheep erythrocytes (SRBC), onto which BTV had been absorbed, served as the indicator of lysis due to the presence of BTV antibody-forming cells. The ratio of BTV to SRBC was found to be critical for optimum hemolytic plaque formation.
R A, Oellermann, P, Carter, M J, Marx
openaire   +4 more sources

Immunological Unresponsiveness Induced by Cryptococcal Capsular Polysaccharide Assayed by the Hemolytic Plaque Technique [PDF]

Infection and Immunity, 1972
Numerous studies have suggested that cryptococcal capsular polysaccharide could induce an immunological paralysis. To investigate this possibility, mice were given various concentrations of purified cryptococcal polysaccharide and then 14 days later were challenge-immunized with the same material in Freund's incomplete adjuvant.
J W, Murphy, G C, Cozad
openaire   +4 more sources

Adaptation of the Hemolytic Plaque Technique for Enumeration of Immune Cells Responding to Heterologous Immunoglobulin Antigens

Experimental Biology and Medicine, 1967
SummaryRabbit spleen cells producing antibodies against mouse immunoglobulin antigens were detected by a modification of the hemolytic plaque technique. The peak cellular and serologic response occurred 7 to 8 days following primary immunization and had subsided completely by the fifteenth day.
R F, Barth, B, Merchant
openaire   +4 more sources

Evaluation of Biofilm Inhibitory Activity of Probiotics and Postbiotics Using In Vitro Biofilm Model of Canine Periodontal Disease. [PDF]

Microorganisms
Adib Lesaux A, Cunha E, Ballet N, Oliveira M.   +3 more
europepmc   +1 more source

Antimicrobial Peptides as Novel Ecological Approaches to Caries Prevention. [PDF]

Drug Des Devel Ther
Jiang W, Liu J, Chen A, Zhao T, Xu Z, Xu L, Du Y, Guan X, Ding J, Liu Y, Sun D.   +10 more
europepmc   +1 more source

A high-performance hydrogel platform enabling dual anti-miR-21 and TGF-β1 delivery to improve arterial plaque stability and enhance therapeutic angiogenesis outcomes. [PDF]

Sci Rep
Islam P, Abosalha A, Schaly S, Boyajian JL, Kassab A, Makhlouf S, Santos M, Renesteen E, Shum-Tim C, Pal A, Shum-Tim D, Prakash S.   +11 more
europepmc   +1 more source

Anti-inflammation-based treatment of atherosclerosis using Gliclazide-loaded biomimetic nanoghosts. [PDF]

Sci Rep, 2023
Karami Z, Mehrzad J, Akrami M, Hosseinkhani S.   +3 more
europepmc   +1 more source

Assessment of oral carriage rate of fusobacterium nucleatum among postnatal mothers - An observational study. [PDF]

J Oral Maxillofac Pathol
Kuppusami B, Santhadevy A, Nagaraja V, Giri U, Vidyalakshmi S, Sivaramakrishan M.   +5 more
europepmc   +1 more source

Oral Health Status of People with Sickle Cell Disease at a Major Hospital in Cameroon. [PDF]

Int J MCH AIDS
Agbor AM, Mekendja KF, Che B, Naidoo S.
europepmc   +1 more source

Platelet Membrane Biomimetic Chemiluminescent Nanoparticles for Targeted Therapy of Atherosclerosis. [PDF]

ACS Appl Mater Interfaces
Zhou Q, Huang M, Wang Y, Mu D.
europepmc   +1 more source